Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer.

Gaoqi XuDihong YangHaiying DingLike ZhongJunfeng ZhuXiufang MiXueyuan ZhangZhufeng WuWenxiu XinChunlei LiJiaqi WangLuo Fang

Published in: European journal of clinical pharmacology (2024)

The popPK characteristics of both liposome-encapsulated and free mitoxantrone in patients with relapsed/refractory lymphoma or SCLC were effectively described by a one-compartment model.

Keyphrases

diffuse large b cell lymphoma
small cell lung cancer
acute lymphoblastic leukemia
acute myeloid leukemia
multiple myeloma
hodgkin lymphoma
brain metastases